Home/Filings/4/0001628280-22-000416
4//SEC Filing

Huber Reid M 4

Accession 0001628280-22-000416

CIK 0001358403other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 9:51 AM ET

Size

6.9 KB

Accession

0001628280-22-000416

Insider Transaction Report

Form 4
Period: 2022-01-04
Huber Reid M
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-04+19,49419,494 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-01-0419,4940 total
    Common Stock (19,494 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
  • [F2]The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001607052

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:51 AM ET
Size
6.9 KB